COYA Coya Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$4.81
· of 52w range
· above low
· to high
$3.7152w low
$7.7552w high
Market Cap (MRQ)
$113M
P/E (TTM)
-4.5
EPS (TTM)
$-1.07
Revenue (TTM)
$8M
your badges
52W Range
$4–$8
Analyst Rating
BUY
Price Target
$15
P/E
-4.5
ROE
-60.5%
Net Profit Margin
-270.2%
Your badge strip is empty — pin a metric anywhere on this page.
COYA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.81
Market Cap (MRQ)
$113M
P/E (TTM)
-4.5
EPS (TTM)
$-1.07
Revenue (TTM)
$8M
ROE (TTM)
-60.5%
52W Range
$4–$8
COYA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$8M2022-12-31 → 2025-12-31
EPS$-1.272021-12-31 → 2025-12-31
Net margin-270.2%2023-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | COYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -4.55Y avg ≈-5.2 | ≈-5.2 | · | · | |
| P/S (TTM) | 14.1 | · | 115.3 | Undervalued | |
| P/B (MRQ) | 2.6 | · | 2.8 | Fair value | |
| Price / Cash Flow | -9.4 | · | · | · | |
| Price / Tangible Book | 2.35Y avg ≈2.7 | ≈2.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | COYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -288.7% | · | -2095.7% | Below avg | |
| EBITDA Margin | -283.9% | · | -2095.7% | Below avg | |
| Pretax Margin | -267.1% | · | -2475.3% | Weak | |
| Net Profit Margin (TTM) | -270.2% | · | -2475.7% | In line | |
| ROA (TTM) | -53.7% | · | -55.4% | Top tier | |
| ROE (TTM) | -60.5% | · | -96.1% | Top tier | |
| ROIC | -52.4% | · | -72.7% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | COYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 13.4 | · | 4.4 | Strong liquidity | |
| Quick Ratio | 8.0 | · | 4.1 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | COYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 123.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | COYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | 0.1 | Top tier | |
| Revenue / Employee | ≈$993.2K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.09%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.28 | $-0.35 | 19.3% |
| March 31, 2026 | May 11, 2026 | $-0.32 | $-0.42 | 24.1% |
| Dec. 31, 2025 | $-0.34 | $-0.28 | -22.2% | |
| Sept. 30, 2025 | $-0.13 | $-0.28 | 53.4% | |
| June 30, 2025 | $-0.36 | $-0.40 | 10.2% | |
| March 31, 2025 | $-0.44 | $-0.20 | -121.2% | |
| Dec. 31, 2024 | $-0.17 | $-0.27 | 37.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $8M | $4M | $6M | $0 | |
| SG&A Expense | $11M | $9M | $8M | $5M | |
| Operating Expenses | $31M | $21M | $14M | $10M | |
| Operating Income | $-23M | $-17M | $-8M | $-10M | |
| Other Non-op | $1M | $2M | $639.4K | $63.7K | |
| Pretax Income | $-21M | $-16M | $-7M | $-12M | |
| Income Tax | $3.1K | $-720.3K | $723.9K | $0 | |
| Net Income | $-21M | $-15M | $-8M | $-12M | |
| EPS (Basic) | $-1.27 | $-0.98 | $-0.79 | $-4.73 | |
| EPS (Diluted) | $-1.27 | $-0.98 | $-0.79 | $-4.73 | |
| Shares (Basic) | 16,730,274 | 15,238,919 | 10,163,850 | 2,590,173 | |
| Shares (Diluted) | 16,730,274 | 15,238,919 | 10,163,850 | 2,590,173 | |
| EBITDA | $-23M | · | $-8M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $38M | $33M | $6M | |
| Prepaid Expense | $3M | $6M | $1M | $1M | |
| Current Assets | $50M | $44M | $41M | $7M | |
| PP&E (Net) | $11.2K | $38.6K | $65.9K | $93.3K | |
| PP&E (Gross) | · | $136.8K | $136.8K | $136.8K | |
| Accum. Depreciation | · | $98.2K | $70.9K | $43.5K | |
| Total Assets | $50M | $44M | $41M | $8M | |
| Accounts Payable | $1M | $2M | $1M | $2M | |
| Accrued Liabilities | $4M | $1M | $3M | $2M | |
| Current Liabilities | $6M | $4M | $5M | $4M | |
| Total Liabilities | $7M | $5M | $6M | $17M | |
| Common Stock | $2.1K | $1.7K | $1.4K | $259 | |
| Paid-in Capital | $105M | $80M | $62M | $681.1K | |
| Retained Earnings | $-62M | $-41M | $-26M | $-18M | |
| Stockholders' Equity | $43M | $40M | $36M | $-8M | |
| Liabilities + Equity | $50M | $44M | $41M | $8M | |
| Shares Outstanding | 20,934,456 | 16,707,441 | 14,405,325 | 2,590,197 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $872.2K | $207.3K | |
| Operating Cash Flow | $-11M | $-10M | $-11M | $-7M | |
| Investing Cash Flow | $-1M | $-25.0K | $-543.2K | $-525.0K | |
| Stock Issued | $20M | $14M | · | · | |
| Net Stock Activity | $20M | · | · | · | |
| Financing Cash Flow | $20M | $16M | $38M | $9M | |
| Taxes Paid | $-730.6K | $734.1K | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -283.9% | · | -131.7% | · | |
| Net Margin | -267.1% | · | -133.1% | · | |
| Pretax Margin | -267.1% | · | -121.0% | · | |
| EBITDA Margin | -283.9% | · | -131.7% | · | |
| ROA | -45.0% | · | -32.2% | · | |
| ROE | -59.5% | · | -34.9% | · | |
| ROIC | -52.4% | · | -24.4% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 8.5 | · | 8.2 | · | |
| Quick Ratio | 8.0 | · | 6.5 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | 0.2 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $2.06 | · | $2.47 | · | |
| Revenue / Share | $0.47 | · | $0.59 | · | |
| Cash Flow / Share | $-0.64 | · | $-1.10 | · | |
| Cash / Share | $2.24 | · | $2.26 | · | |
| EPS (TTM) | $-1.27 | $-0.98 | $-0.79 | $-4.73 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 123.6% | -40.8% | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $8M | $4M | $6M | $0 | |
| Net Income TTM | $-21M | $-15M | $-8M | $-12M | |
| Market Cap | $121M | · | $107M | · | |
| P/E | -4.6 | -5.8 | -9.4 | -1.0 | |
| P/S | 15.3 | · | 17.8 | · | |
| P/B | 2.8 | · | 3.0 | · | |
| P / Tangible Book | 2.8 | 2.4 | 3.0 | · | |
| P / Cash Flow | -11.3 | · | -9.5 | · | |
| Earnings Yield | -21.9% | -17.1% | -10.7% | -99.8% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $243.7K | $251.1K | $4M | $4M | $163.6K | $257.9K | $2.0K | $0 | $3M | $126.8K | $6M | $0 | $0 | $0 | |
| SG&A Expense | $2M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $7M | $8M | $10M | $6M | $7M | $8M | $4M | $4M | $7M | $6M | $4M | $4M | $3M | $3M | |
| Operating Income | $-7M | $-8M | $-6M | $-2M | $-6M | $-8M | $-4M | $-4M | $-3M | $-5M | $2M | $-4M | $-3M | $-3M | |
| Other Non-op | $408.7K | $433.2K | $325.4K | $317.1K | $319.5K | $370.2K | $444.2K | $428.9K | $344.4K | $431.1K | $174.7K | $142.1K | $159.0K | $163.6K | |
| Pretax Income | $-7M | $-7M | · | · | $-6M | $-7M | · | · | $-3M | $-5M | · | · | · | · | |
| Income Tax | · | · | · | · | $0 | · | · | · | $0 | · | · | · | · | · | |
| Net Income | $-7M | $-7M | $-6M | $-2M | $-6M | $-7M | $-3M | $-4M | $-3M | $-5M | $1M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $-0.28 | $-0.32 | $-0.34 | $-0.13 | $-0.36 | $-0.44 | $-0.18 | $-0.26 | $-0.19 | $-0.35 | $0.14 | $-0.34 | $-0.31 | $-0.28 | |
| EPS (Diluted) | $-0.28 | $-0.32 | $-0.34 | $-0.13 | $-0.36 | $-0.44 | $-0.18 | $-0.26 | $-0.19 | $-0.35 | $0.14 | $-0.34 | $-0.31 | $-0.28 | |
| Shares (Basic) | 23,457,227 | 22,644,304 | · | 16,732,766 | 16,724,998 | 16,720,511 | · | 15,221,308 | 14,915,217 | 14,457,839 | · | 9,947,915 | 9,947,915 | 9,721,847 | |
| Shares (Diluted) | 23,457,227 | 22,644,304 | · | 16,732,766 | 16,724,998 | 16,720,511 | · | 15,221,308 | 14,915,217 | 14,457,839 | · | 9,947,915 | 9,947,915 | 9,721,847 | |
| EBITDA | $-7M | $-8M | · | $-2M | $-6M | $-8M | · | $-4M | $-3M | $-5M | · | $-4M | $-3M | $-3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $51M | $47M | $28M | $30M | $36M | $38M | $31M | $37M | $36M | $33M | $11M | $13M | $16M | |
| Prepaid Expense | $4M | $3M | $3M | $4M | $4M | $3M | $6M | $4M | $3M | $1M | $1M | $936.4K | $1M | $1M | |
| Current Assets | $47M | $53M | $50M | $32M | $33M | $38M | $44M | $36M | $40M | $37M | $41M | $12M | $14M | $17M | |
| PP&E (Net) | $5.6K | $8.4K | $11.2K | $18.1K | $24.9K | $31.7K | $38.6K | $45.4K | $52.3K | $59.1K | $65.9K | $72.8K | $79.6K | $86.5K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $136.8K | · | · | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $70.9K | · | · | · | |
| Other Non-current Assets | $244.7K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $47M | $53M | $50M | $32M | $33M | $38M | $44M | $36M | $40M | $37M | $41M | $12M | $14M | $17M | |
| Accounts Payable | $1M | $948.2K | $1M | $1M | $931.3K | $2M | $2M | $336.7K | $2M | $2M | $1M | $634.0K | $237.6K | $541.8K | |
| Accrued Liabilities | $1M | $1M | $4M | $2M | $3M | $2M | $1M | $1M | $1M | $2M | $3M | $1M | $983.6K | $724.7K | |
| Current Liabilities | $4M | $4M | $6M | $4M | $5M | $4M | $4M | $2M | $4M | $4M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $4M | $4M | $7M | $5M | $5M | $5M | $5M | $4M | $5M | $5M | $6M | $2M | $1M | $1M | |
| Common Stock | $2.3K | $2.3K | $2.1K | $1.7K | $1.7K | $1.7K | $1.7K | $1.5K | $1.5K | $1.5K | $1.4K | $996 | $996 | $996 | |
| Paid-in Capital | $119M | $118M | $105M | $84M | $82M | $81M | $80M | $70M | $69M | $63M | $62M | $37M | $37M | $37M | |
| Retained Earnings | $-76M | $-69M | $-62M | $-56M | $-54M | $-48M | $-41M | $-38M | $-34M | $-31M | $-26M | $-27M | $-24M | $-21M | |
| Stockholders' Equity | $43M | $49M | $43M | $27M | $28M | $33M | $40M | $32M | $35M | $32M | $36M | $10M | $13M | $16M | |
| Liabilities + Equity | $47M | $53M | $50M | $32M | $33M | $38M | $44M | $36M | $40M | $37M | $41M | $12M | $14M | $17M | |
| Shares Outstanding | 23,457,849 | 23,457,183 | 20,934,456 | 16,742,638 | 16,724,998 | 16,724,998 | 16,707,441 | 15,221,308 | 15,221,308 | 14,613,172 | 14,405,325 | 9,947,915 | 9,947,915 | 9,947,915 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $943.9K | $2M | $1M | $1M | $1M | $1M | $790.5K | $775.0K | $662.3K | $435.7K | $238.0K | $262.8K | $191.1K | $180.4K | |
| Operating Cash Flow | $-7M | $-6M | $-1M | $-1M | $-6M | $-3M | $-2M | $-5M | $-5M | $2M | $-2M | $-2M | $-3M | $-4M | |
| Investing Cash Flow | $-1.7K | $-885.0K | $-648.6K | · | · | · | $0 | $0 | $0 | $-25.0K | $-193.2K | $0 | · | · | |
| Stock Issued | $-41.8K | $11M | · | · | · | · | $9M | $-56.3K | · | · | · | · | · | · | |
| Net Stock Activity | · | $11M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-166.1K | $11M | $20M | $19.1K | $0 | $19.1K | $10M | $-56.3K | $5M | $1M | $24M | $0 | $0 | $14M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2891.1% | -3042.1% | · | -68.3% | -3920.5% | -2976.9% | · | · | -94.5% | -4322.8% | · | · | · | · | |
| Net Margin | -2723.4% | -2869.6% | · | -59.4% | -3725.2% | -2833.3% | · | · | -84.4% | -3983.0% | · | · | · | · | |
| Pretax Margin | -2723.4% | -2869.6% | · | · | -3725.2% | -2833.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -2891.1% | -3042.1% | · | -68.3% | -3920.5% | -2976.9% | · | · | -94.5% | -4322.8% | · | · | · | · | |
| ROA | -16.4% | -15.7% | · | -6.3% | -16.6% | -19.3% | · | -17.0% | -10.6% | -18.4% | · | -57.5% | -42.8% | -31.4% | |
| ROE | -18.6% | -17.5% | · | -7.1% | -19.2% | -22.2% | · | -19.1% | -11.9% | -20.8% | · | -67.8% | -46.7% | -33.9% | |
| ROIC | · | · | · | · | -22.7% | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.4 | 15.0 | · | 8.7 | 7.4 | 8.8 | · | 15.3 | 10.4 | 8.6 | · | 6.5 | 11.8 | 13.7 | |
| Quick Ratio | 12.3 | 14.3 | · | 7.7 | 6.6 | 8.2 | · | 13.4 | 9.6 | 8.3 | · | 6.0 | 10.7 | 12.9 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.84 | $2.09 | · | $1.63 | $1.69 | $2.00 | · | $2.10 | $2.32 | $2.22 | · | $1.01 | $1.33 | $1.62 | |
| Revenue / Share | $0.01 | $0.01 | · | $0.21 | $0.01 | $0.02 | · | $0.00 | $0.23 | $0.01 | · | · | · | · | |
| Cash Flow / Share | · | $-0.27 | · | · | · | $-0.17 | · | · | · | $0.15 | · | · | · | $-0.40 | |
| Cash / Share | $1.84 | $2.16 | · | $1.68 | $1.78 | $2.12 | · | $2.04 | $2.40 | $2.46 | · | $1.09 | $1.32 | $1.64 | |
| EPS (TTM) | $-1.07 | $-1.15 | · | $-1.11 | $-1.24 | $-1.07 | · | $-0.66 | $-0.74 | $-0.86 | · | $-2.13 | $-3.34 | $-4.35 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $8M | · | $4M | $423.5K | $4M | · | $10M | $10M | $6M | · | · | · | · | |
| Net Income TTM | $-22M | $-21M | · | $-18M | $-20M | $-17M | · | $-11M | $-10M | $-10M | · | $-12M | $-13M | $-13M | |
| Market Cap | $137M | $92M | · | $95M | $96M | $108M | · | $98M | $92M | $145M | · | $38M | $40M | $40M | |
| P/E | -5.5 | -3.4 | · | -5.1 | -4.6 | -6.0 | · | -9.8 | -8.2 | -11.5 | · | -1.8 | -1.2 | -0.9 | |
| P/S | 17.1 | 11.6 | · | 23.9 | 227.1 | 29.4 | · | 10.3 | 9.7 | 23.7 | · | · | · | · | |
| P/B | 3.2 | 1.9 | · | 3.5 | 3.4 | 3.2 | · | 3.1 | 2.6 | 4.5 | · | 3.8 | 3.1 | 2.4 | |
| P / Tangible Book | 3.2 | 1.9 | · | 3.5 | 3.4 | 3.2 | · | 3.1 | 2.6 | 4.5 | · | 3.8 | 3.1 | 2.4 | |
| P / Cash Flow | · | -14.9 | · | · | · | -38.3 | · | · | · | 67.6 | · | · | · | -10.2 | |
| Earnings Yield | -18.3% | -29.2% | · | -19.5% | -21.6% | -16.5% | · | -10.2% | -12.2% | -8.7% | · | -55.5% | -82.1% | -109.5% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $8M | $4M | $6M | $0 | · |
| Operating Margin % | -283.9% | · | -131.7% | · | · |
| Net Income | $-21M | $-15M | $-8M | $-12M | $-5M |
| Diluted EPS | $-1.27 | $-0.98 | $-0.79 | $-4.73 | $-1.89 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 8.5 | · | 8.2 | · | · |
| Quick Ratio | 8.0 | · | 6.5 | · | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 56 filers · $51.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
56
Value held
$51.0M
New positions
5
Exited positions
7
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-9 vs prior Q) | 7 (-4 vs prior Q) | 14 (-6 vs prior Q) | 17 (+6 vs prior Q) | -388K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| DME Capital Management, LP | $13,662,909 | 2,335,540 | 26.81% | Shares |
| VANGUARD GROUP INC | $5,215,012 | 899,140 | 10.23% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,926,987 | 842,220 | 9.67% | Shares |
| Alyeska Investment Group, L.P. | $4,680,000 | 800,000 | 9.18% | Shares |
| AIGH Capital Management LLC | $3,696,685 | 631,912 | 7.25% | Shares |
| CM Management, LLC | $2,340,000 | 400,000 | 4.59% | Shares |
| PRIVATE MANAGEMENT GROUP INC | $2,247,669 | 384,217 | 4.41% | Shares |
| MARSHALL WACE, LLP | $1,461,289 | 249,793 | 2.87% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,335,507 | 228,243 | 2.62% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,128,968 | 192,986 | 2.22% | Shares |
| Prosight Management, LP | $994,500 | 170,000 | 1.95% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $913,036 | 155,917 | 1.79% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $757,873 | 129,551 | 1.49% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $610,005 | 110,910 | 1.20% | Shares |
| BlackRock, Inc. | $599,087 | 102,408 | 1.18% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $592,781 | 101,330 | 1.16% | Shares |
| JBF Capital, Inc. | $585,035 | 100,006 | 1.15% | Shares |
| ROYAL BANK OF CANADA | $546,000 | 93,414 | 1.07% | Shares |
| MORGAN STANLEY | $480,320 | 82,106 | 0.94% | Shares |
| STATE STREET CORP | $466,906 | 79,813 | 0.92% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $356,885 | 61,006 | 0.70% | Shares |
| JANE STREET GROUP, LLC | $344,565 | 58,900 | 0.68% | Call option |
| NORTHERN TRUST CORP | $263,671 | 45,072 | 0.52% | Shares |
| XTX Topco Ltd | $242,196 | 41,401 | 0.48% | Shares |
| ADAR1 Capital Management, LLC | $239,265 | 40,900 | 0.47% | Shares |
| Long Corridor Asset Management Ltd | $226,781 | 38,766 | 0.45% | Shares |
| Cetera Investment Advisers | $198,900 | 34,000 | 0.39% | Shares |
| Squarepoint Ops LLC | $194,571 | 33,260 | 0.38% | Shares |
| UBS Group AG | $193,565 | 33,088 | 0.38% | Shares |
| Quadrature Capital Ltd | $180,081 | 30,783 | 0.35% | Shares |
| GOLDMAN SACHS GROUP INC | $153,153 | 26,180 | 0.30% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $120,662 | 20,626 | 0.24% | Shares |
| AXQ CAPITAL, LP | $115,883 | 19,809 | 0.23% | Shares |
| OPPENHEIMER & CO INC | $105,300 | 18,000 | 0.21% | Shares |
| GHP Investment Advisors, Inc. | $103,114 | 26,171 | 0.20% | Shares |
| Jump Financial, LLC | $101,205 | 17,300 | 0.20% | Shares |
| OCCUDO QUANTITATIVE STRATEGIES LP | $98,415 | 16,823 | 0.19% | Shares |
| CITADEL ADVISORS LLC | $76,664 | 13,105 | 0.15% | Shares |
| Allworth Financial LP | $76,050 | 13,000 | 0.15% | Shares |
| RAYMOND JAMES FINANCIAL INC | $59,816 | 10,225 | 0.12% | Shares |
| HighTower Advisors, LLC | $58,670 | 10,029 | 0.12% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $58,500 | 10,000 | 0.11% | Shares |
| Vanguard Global Advisers, LLC | $34,392 | 5,879 | 0.07% | Shares |
| JPMORGAN CHASE & CO | $31,449 | 5,181 | 0.06% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $27,864 | 4,763 | 0.05% | Shares |
| BFSG, LLC | $20,212 | 3,455 | 0.04% | Shares |
| Rockefeller Capital Management L.P. | $11,700 | 2,000 | 0.02% | Shares |
| IFP Advisors, Inc | $11,700 | 2,000 | 0.02% | Shares |
| SBI Securities Co., Ltd. | $4,797 | 820 | 0.01% | Shares |
| Steward Partners Investment Advisory, LLC | $2,925 | 500 | 0.01% | Shares |
Company insiders 12 insiders · 5 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Arun Swaminathan | Chief Executive Officer | Jan. 22, 2026 A | 10,000 | 0 | 0 | $0 |
| David S Snyder | Chief Financial Officer | Jan. 22, 2026 A | 8,800 | 0 | 0 | $0 |
| Fred Grossman | Chief Medical Officer | Jan. 22, 2026 A | 2,710 | 0 | 0 | $0 |
| Berman Howard H. | Executive Chairman | Jan. 22, 2026 A | 10,000 | 0 | 0 | $0 |
| Adrian Hepner | Chief Medical Officer | Feb. 27, 2023 A | 10,000 | 0 | 0 | $0 |
| Mark H Pavao | Director | April 9, 2026 A | · | 0 | 0 | $0 |
| Ann Lee | Director | Jan. 2, 2026 A | 17,479 | 0 | 0 | $0 |
| Anabella Villalobos | Director | Jan. 2, 2026 A | 10,000 | 0 | 0 | $0 |
| Dieter Weinand | Director | Jan. 2, 2026 A | · | 0 | 0 | $0 |
| GOLDSTEIN DOV A MD | Director | Jan. 2, 2026 A | 27,557 | 0 | 0 | $0 |
| Wilbur L Ross JR | Director | Jan. 2, 2026 A | · | 0 | 0 | $0 |
| Hideki Garren | Director | Jan. 1, 2024 A | 2,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 8 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.02% | 65,475 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.00% | 4,793 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 75,558 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 2,845 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 219,955 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 601,117 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 1,977 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 137 NS | July 31, 2026 | N-PORT |
COYA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$15.50
+222.2%
3 23.1%
Strong Buy
9 69.2%
Buy
1 7.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
7 analysts · 2026-09-28Mean target $15.21 +216.3%
← Below all targets
Current price $4.81
Low$12.00
Mean$15.21
High$18.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| IMUX | · | -0.9 | · | · | · | · |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026